Maria Domenica Cappellini

Maria Domenica Cappellini

UI Designer

Biography

Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Aenean eu leo quam. Pellentesque ornare sem lacinia quam venenatis vestibulum. Sed posuere consectetur est at lobortis. Cras mattis consectetur purus sit amet fermentum.

Curabitur blandit tempus porttitor. Nullam quis risus eget urna mollis ornare vel eu leo. Nullam id dolor id nibh ultricies vehicula ut id elit.

Etiam porta sem malesuada magna mollis euismod. Cras mattis consectetur purus sit amet fermentum. Aenean lacinia bibendum nulla sed consectetur.

Vivamus sagittis lacus vel augue laoreet rutrum faucibus dolor auctor. Duis mollis, est non commodo luctus, nisi erat porttitor ligula, eget lacinia odio sem nec elit. Morbi leo risus, porta ac consectetur ac, vestibulum at eros.

Sub-heading

Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.

Aenean lacinia bibendum nulla sed consectetur. Etiam porta sem malesuada magna mollis euismod. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa.

Another heading

Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Aenean lacinia bibendum nulla sed consectetur. Etiam porta sem malesuada magna mollis euismod. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus.

  • Praesent commodo cursus magna, vel scelerisque nisl consectetur et.
  • Donec id elit non mi porta gravida at eget metus.
  • Nulla vitae elit libero, a pharetra augue.

Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Aenean lacinia bibendum nulla sed consectetur. Etiam porta sem malesuada magna mollis euismod. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus.

Penatibus et magnis dis parturient montes, nascetur ridiculus mus. Aenean lacinia bibendum nulla sed consectetur. Etiam porta sem malesuada magna mollis euismod. Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus.

All session by Carol Wood

Registrations

PLENARY ROOM (Aula Magna “M. Vignola”)

08.00 | 08.30

Welcome address

Antonis Kattamis (Greece), Aurelio Maggio (Italy), Ali Taher (Lebanon)

08.30 | 08.45

Greetings from local Authorities

08.45 | 09.00

Introduction: Is it time to revisit classification of Thalassemia Syndromes ?

Aurelio Maggio (Italy)

09.00 | 09.15

THALASSEMIA MAJOR AND ANTIVIRAL TREATMENT

CHAIRPERSONS: Antonis Kattamis (Greece), Antonio Piga (Italy)

SESSION I

Transfusion therapy: what is new with respect to safety and control of iron loading?

Yesim Aydinok (Turkey)

09.15 | 09.30

The future of thalassemia patients without HCV infection: a new history

Vito Di Marco (Italy)

09.30 | 09.45

Interactive Discussion: what is the state of art in transfusion safety and anti-viral treatment of Thalassemia Syndromes worldwide ? Comparing experiences from France, India, Iran, Italy, Saudi Arabia:

Caterina Borgna Pignatti (Italy), Mahmoud Hajipour (Iran), Olivier Hermine (France), Farrukh Shah (KSA), Alok Srivastava (India)

09.45 | 10.30

Discussion

10.30 | 10.45

Coffee Break

10.45 | 11.00

THALASSEMIA INTERMEDIA

CHAIRPERSONS: Caterina Borgna Pignatti (Italy), Vip Viprakasit (Thailand)

SESSION II

Thalassemia Intermedia: is disease morbidity as we know it today less severe than Thalassemia Major ?

Ali Taher (Lebanon)

11.00 | 11.20

Hypercoagulable state in thalassemia

Eliezer Rachmilewitz (Israel)

11.20 | 11.40

General insights and current management of Thalassemia Intermedia

Maria Domenica Cappellini (Italy)

11.40 |12:00

Interactive Discussion: what is the state of art in Thalassemia Intermedia management worldwide ? Comparing experiences from Iran, Italy, Malaysia, Qatar:

Ibrahim Hishamshah (Malaysia), Mehran Karimi (Iran), Paolo Ricchi (Italy), Mahamoud Yassin (Qatar)

12.00 | 12.40

Discussion

12.40 | 13.00

Light Lunch

13.00 | 14.00

THE NEW ERA OF CHELATION TREATMENT

CHAIRPERSONS: Adriana Ceci (Italy), Alan Cohen (USA)

SESSION III

How the era of the new chelators is changing prognosis of Thalassemia Syndromes

John Porter (UK)

14.00 | 14.15

Effectiveness and safety of 10 different regimens for controlling iron overloading in Thalassemia Major

Aurelio Maggio (Italy)

14.15 | 14.30

Iron overload and Chelation Therapy in Thalassemia Intermedia

Ali Taher (Lebanon)

14.30 | 14.45

Interactive Discussion: what is the state of art in chelation management of Thalassemia Syndromes worldwide ? Comparing experiences from Italy, Kuwait, Oman, Pakistan:

Kunle Adekile (Kuwait), Shahina Daar (Oman), Aldo Filosa (Italy), Saqib Hussein Ansari (Pakistan)

14.45 | 15.30

Discussion

15.30 | 15.45

HIGHLIGHTS IN MANAGEMENT OF THALASSEMIA SYNDROMES IN EASTERN COUNTRIES

CHAIRPERSONS: Marie-Charlotte Bouesseau (Switzerland), Suthat Fucharoen (Thailand)

SESSION IV

Management of Thalassemia Syndromes in Egypt: what has been changing during the last 10 years?

Amal El-Beshlawy (Egypt)

15.45 | 16.05

Current management of Thalassemia Syndromes in Thailand: past, present and future

Vip Viprakasit (Thailand)

16.05 | 16.25

Discussion

16.25 | 16.45

MRI AND CURRENT MANAGEMENT OF THALASSEMIA SYNDROMES

CHAIRPERSONS: Gian Luca Forni (Italy), Paul Telfer (UK)

SESSION V

The impact of MRI in changing prognosis of Thalassemia Major

Dudley Pennell (UK)

16.45 | 17.05

The MIOT network: an Italian model for management of Thalassemia Syndromes

Alessia Pepe (Italy)

17.05 | 17.25

Interactive Discussion: what is the state of art in MRI facilities worldwide? Comparing experiences from Egypt, France, India, Saudi Arabia and Thailand:

Amal El-Beshlawy (Egypt), Olivier Hermine (France), Alok Srivastava (India), Farrukh Shah (KSA), Vip Viprakasit (Thailand)

17.25 | 18.15

Discussion

18:15 | 18.30

NOVEL STRATEGIES FOR THE TREATMENT OF THALASSEMIA SYNDROMES

CHAIRPERSONS: Paolo Moi (Italy), Ali Taher (Lebanon)

SESSION VI

Highlights on gene therapy in haemoglobinopathies

Marina Cavazzana (France)

18.30 | 18.50

New pharmacological approches for increasing hemoglobin levels in Thalassemia Syndromes

Antonio Piga (Italy)

18:50 | 19.10

Conclusions

Aurelio Maggio (Italy)

19.10 | 19.30

Hepcidin and iron overload (NO CME)

Sponsored talk by La Jolla Pharmaceutical

Lakhmir S. Chawla (US)

19.30 | 19.45

(Simultaneous sessions) Panel discussion on RECOMMENDATIONS FOR INITIAL EVALUATION AND STAGING ASSESSMENT OF THALASSEMIA SYNDROMES

SESSION VII

PANEL I (Meeting Room: Aula Fici)

CHAIRPERSONS: Alan Cohen (US), Antonis Kattamis (Greece)

DISCUSSANTS: Marie-Charlotte Bouesseau; Marina Cavazzana, Gianluca Forni, Suthat Fucharoen, Olivier Hermine, Ansari Saqib Hussain, Mehran Karimi, Antonio Piga, John Porter, Paolo Ricchi, Farrukh Shah, Alok Srivatsava, Paul Telfer, Elliott Vichinsky, Vip Viprakasit

08.30 | 10.30

PANEL II (Meeting Room: Biblioteca)

CHAIRPERSONS: Amal El-Beshlawy (Egypt), Ali Taher (Lebanon)

DISCUSSANTS: Kunle Adekile, Yesim Aydinok, Caterina Borgna Pignatti, Maria Domenica Cappellini, Adriana Ceci, Shahina Daar, Vito Di Marco, Aldo Filosa, Mahmoud Hajipour, Ibrahim Hishamshah, Aurelio Maggio, Dudley Pennell, Alessia Pepe, Eliezer Rachmilewitz, Mahmoud Yassin

08.30 | 10.30

Coffee Break

10.30 | 10.45

PLENARY ROOM (Aula Magna “M.Vignola”)

CHAIRPERSONS: Aurelio Maggio (Italy), Ali Taher (Lebanon), Paul Telfer (UK), Elliott Vichinsky (US)

Presentation of Panel I – Recommendations for initial evaluation and staging assessment of Thalassemia Syndromes

Alan Cohen (US), Antonis Kattamis (Greece)

10.45 | 11.15

Presentation of Panel II – Recommendations for initial evaluation and staging assessment of Thalassemia Syndromes

Amal El-Beshlawy (Egypt), Ali Taher (Lebanon)

11.15 | 11.45

Discussion for general consensus on Presentations of Panel I and II

11.45 | 12.30

Final proposal and future strategy

Aurelio Maggio (Italy)

12.30 | 13.00

CME questionnaire

13.00 | 13.15

Closing remarks

Aurelio Maggio (Italy)

13.15 | 13.30

Light Lunch

13.30 | 14.30

Poster Session I on (NO CME)

THALASSEMIA MAJOR AND ANTIVIRAL TREATMENT, THALASSEMIA INTERMEDIA AND THE NEW ERA OF CHELATION TREATMENT

14.30 | 16.00

Poster Session II on (NO CME)

HIGHLIGHTS IN MANAGEMENT OF THALASSEMIA SYNDROMES IN EASTERN COUNTRIES, MRI AND CURRENT MANAGEMENT OF THALASSEMIA SYNDROMES AND NOVEL STRATEGIES FOR THE TREATMENT OF THALASSEMIA SYNDROMES

16.00 | 17.30

Conclusions

Aurelio Maggio (Italy)

17.30 | 17.45
back to top